Top Markets
#1 Galxe Galxe +87.79%
#2 Akedo Akedo +81.34%
#3 Gravity Gravity +56.29%
#4 Starknet Starknet +48.50%
#5 Bedrock Bedrock +44.79%
#6 Pearl Pearl +40.83%
#7 Railgun Railgun +38.97%
#8 TENDIES TENDIES +35.36%
#9 Pieverse Pieverse +34.15%
#10 MYX Finance MYX Finance +32.21%
Coin of the day
Galxe Galxe
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVXA
Hisse Senetlerindeki Sıralama #38483
Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc... Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc operates as a clinical-stage biopharmaceutical firm dedicated to discovering and bringing to market innovative therapies for various female sexual dysfunctions. Its primary drug candidate, BP-101, is being developed as a medical treatment for premenopausal women diagnosed with hypoactive sexual desire disorder. This compound is presently in Phase II clinical investigation in Australia and New Zealand, and has progressed to Phase III clinical trials within Russia. Beyond its core pharmaceutical work, the company also participates in mineral exploration and offers supplementary support services. The organization, originally incorporated as Ovoca Gold plc, rebranded to Ovoca Bio plc in July 2018.
Hisse Fiyatı
$0.01142111
Son senkronizasyon: 2025-03-21
Piyasa Değeri
$930.66K
Değişim (1 gün)
0.18%
Değişim (1 yıl)
-69.73%
Ülke
IE
Ticaret Ovoca Bio plc (OVXA)

Kategori

Healthcare
Ovoca Bio plc (OVXA) için P/B oranı
September 2026 itibarıyla P/B oranı TTM: 3.38
Ovoca Bio plc şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) 3.38'dir. 2022 yılının sonunda şirketin P/B oranı 0.64 idi.
Ovoca Bio plc için P/B oranı geçmişi 2001 - 2026 arası
Her yılın sonunda P/B oranı
Yıl P/B Oranı Değiştir
2026 (TTM) 3.38 1,025.17%
2023 0.30 -53.15%
2022 0.64 -29.64%
2021 0.91 118.10%
2020 0.42 -3.84%
2019 0.43 -6.34%
2018 0.46 53.47%
2017 0.30 -32.59%
2016 0.45 47.37%
2015 0.30 -7.99%
2014 0.33 9.22%
2013 0.30 -0.88%
2012 0.31 -37.76%
2011 0.49 -30.05%
2010 0.70 56.65%
2009 0.45 86.66%
2008 0.24 -82.53%
2007 1.37 8.35%
2006 1.27 -10.71%
2005 1.42 46.67%
2004 0.97 -4.43%
2003 1.01 -25.12%
2002 1.35 -22.97%
2001 1.76 0.00%
Benzer şirketler veya rakipler için P/B oranı
Şirket P/B Oranı P/B Oranı Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.5144 92.99%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.3983 119.18%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.5918 154.53%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9974 18.42%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH